Literature DB >> 22773876

GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).

Li Wang1, Yi Jia, Heather Rogers, Yun-Ping Wu, Suming Huang, Constance Tom Noguchi.   

Abstract

Erythropoietin (EPO), the cytokine required for erythrocyte production, contributes to muscle progenitor cell proliferation and delay myogenic differentiation. However, the underlying mechanism is not yet fully understood. Here, we report that EPO changes the skeletal myogenic regulatory factor expression program and delays differentiation via induction of GATA-4 and the basic helix-loop-helix TAL1 and that knockdown of both factors promotes differentiation. EPO increases the Sirt1 level, a NAD(+)-dependent deacetylase, and also induces the NAD(+)/NADH ratio that further increases Sirt1 activity. Sirt1 knockdown reduced GATA-4 and TAL1 expression, impaired EPO effect on delayed myogenic differentiation, and the Sirt1 knockdown effect was abrogated when combined with overexpression of GATA-4 or TAL1. GATA-4 interacts with Sirt1 and targets Sirt1 to the myogenin promoter and represses myogenin expression, whereas TAL1 inhibits myogenin expression by decreasing MyoD binding to and activation of the myogenin promoter. Sirt1 was found to bind to the GATA-4 promoter to directly regulate GATA-4 expression and GATA-4 binds to the TAL1 promoter to regulate TAL1 expression positively. These data suggest that GATA-4, TAL1, and Sirt1 cross-talk each other to regulate myogenic differentiation and mediate EPO activity during myogenic differentiation with Sirt1 playing a role upstream of GATA-4 and TAL1. Taken together, our findings reveal a novel role for GATA-4 and TAL1 to affect skeletal myogenic differentiation and EPO response via cross-talk with Sirt1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773876      PMCID: PMC3436270          DOI: 10.1074/jbc.M112.376640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.

Authors:  J Landry; A Sutton; S T Tafrov; R C Heller; J Stebbins; L Pillus; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.

Authors:  P L Puri; S Iezzi; P Stiegler; T T Chen; R L Schiltz; G E Muscat; A Giordano; L Kedes; J Y Wang; V Sartorelli
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.

Authors:  J Lu; T A McKinsey; C L Zhang; E N Olson
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

4.  Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.

Authors:  M Ogilvie; X Yu; V Nicolas-Metral; S M Pulido; C Liu; U T Ruegg; C T Noguchi
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

5.  Mouse lacking NAD+-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle.

Authors:  M J MacDonald; L K Marshall
Journal:  Arch Biochem Biophys       Date:  2000-12-01       Impact factor: 4.013

6.  Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.

Authors:  M V Chakravarthy; T W Abraha; R J Schwartz; M L Fiorotto; F W Booth
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

8.  Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage.

Authors:  Yi Jia; Norio Suzuki; Masayuki Yamamoto; Max Gassmann; Constance Tom Noguchi
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

9.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

Authors:  A Mal; M Sturniolo; R L Schiltz; M K Ghosh; M L Harter
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice.

Authors:  Changtao Jiang; Aijuan Qu; Tsutomu Matsubara; Tatyana Chanturiya; William Jou; Oksana Gavrilova; Yatrik M Shah; Frank J Gonzalez
Journal:  Diabetes       Date:  2011-08-26       Impact factor: 9.461

View more
  19 in total

1.  AMPK is involved in mediation of erythropoietin influence on metabolic activity and reactive oxygen species production in white adipocytes.

Authors:  Li Wang; Lijun Di; Constance Tom Noguchi
Journal:  Int J Biochem Cell Biol       Date:  2014-06-19       Impact factor: 5.085

2.  Charting a course for erythropoietin in traumatic brain injury.

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2016-03-26

Review 3.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

4.  Wnt/β-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis.

Authors:  Li Wang; Li-jun Di
Journal:  J Biol Chem       Date:  2015-06-24       Impact factor: 5.157

5.  Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation.

Authors:  Xiaomeng Jia; Huijiao Liu; Xinmin Ren; Peng Li; Runjie Song; Xiru Li; Yangdong Guo; Xiangdong Li
Journal:  Oncogene       Date:  2022-08-27       Impact factor: 8.756

6.  Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation.

Authors:  Li Wang; Yi Jia; Heather Rogers; Norio Suzuki; Max Gassmann; Qian Wang; Alexandra C McPherron; Jeffery B Kopp; Masayuki Yamamoto; Constance Tom Noguchi
Journal:  Int J Biochem Cell Biol       Date:  2013-03-20       Impact factor: 5.085

7.  T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Authors:  Heather Rogers; Li Wang; Xiaobing Yu; Mawadda Alnaeeli; Kairong Cui; Keji Zhao; James J Bieker; Josef Prchal; Suming Huang; Babette Weksler; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-09-16       Impact factor: 5.157

8.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

9.  The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?

Authors:  Séverine Lamon; Aaron P Russell
Journal:  Front Physiol       Date:  2013-07-15       Impact factor: 4.566

Review 10.  Erythropoietin action in stress response, tissue maintenance and metabolism.

Authors:  Yuanyuan Zhang; Li Wang; Soumyadeep Dey; Mawadda Alnaeeli; Sukanya Suresh; Heather Rogers; Ruifeng Teng; Constance Tom Noguchi
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.